You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Saponin QA-21V1

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Squamous Cell Carcinoma of Larynx Trial in São Paulo (carboplatin AUC of 6, paclitaxel 175 mg/m2, and pembrolizumab 200 mg, i.v.

Recruiting
  • Squamous Cell Carcinoma of Larynx
  • carboplatin AUC of 6, paclitaxel 175 mg/m2, and pembrolizumab 200 mg, i.v. on day 1, every 21 days for 3 cycles
  • +2 more
  • São Paulo, Brazil
    Beneficiencia Portuguesa de São Paulo/Hospital São José
Dec 22, 2022

Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia Trial (Blinatumomab)

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • Mixed Phenotype Acute Leukemia
  • (no location specified)
Apr 7, 2022

Evaluation of the PI-RADS v2.1 Score Using Multiple Readers

Completed
  • Prostate Cancer
  • Urological Cancer
  • Assessment of the accuracy of the PI-RADS v2.1 score for predicting the presence of ISUP ≥2 prostate cancer at subsequent biopsy in the dataset of the 171 MRIs for 21 different readers.
  • Lyon, France
    Hôpital Edouard Herriot
Feb 28, 2022

Atrial Fibrillation Trial in Worldwide (OMNYPULSE Bi-Directional Catheter with TRUPULSE Generator)

Not yet recruiting
  • Atrial Fibrillation
  • OMNYPULSE Bi-Directional Catheter with TRUPULSE Generator
  • Aalst, Belgium
  • +12 more
Jul 25, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +20 more
  • Neoantigen Peptide Vaccine
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 7, 2022

COVID-19 Trial in Canada, Poland, Romania (GS-5245, GS-5245 Placebo)

Recruiting
  • COVID-19
  • Hamilton, Canada
  • +8 more
Jan 24, 2023

Familial Chylomicronemia Syndrome Trial in Canada, Sweden, United States (Olezarsen)

Recruiting
  • Familial Chylomicronemia Syndrome
  • Huntington Beach, California
  • +10 more
Aug 4, 2022

Homozygous Familial Hypercholesterolemia Trial in Australia, Canada, United States (ARO-ANG 3 Injection)

Recruiting
  • Homozygous Familial Hypercholesterolemia
  • ARO-ANG 3 Injection
  • Mount Sinai, New York
  • +7 more
Sep 26, 2022

Brodalumab in Plaque Psoriasis to Understand Impact on Quality

Recruiting
  • Psoriasis
  • Brodalumab
  • Matched cohort
  • Calgary, Alberta, Canada
  • +33 more
Oct 8, 2022

Covid19 Trial in Worldwide (C21, Placebo)

Completed
  • Covid19
  • Orange, California
  • +60 more
Sep 8, 2022

Respiratory Syncytial Virus Trial in Worldwide (mRNA-1345)

Not yet recruiting
  • Respiratory Syncytial Virus
  • mRNA-1345
  • Glendale, Arizona
  • +47 more
Sep 27, 2023

Pneumococcal Disease Trial in Chile, United States (V116, Placebo, PCV15)

Active, not recruiting
  • Pneumococcal Disease
  • V116
  • +3 more
  • Phoenix, Arizona
  • +19 more
Dec 21, 2022

Melanoma Trial in Canada, United States (rIL-21, Dacarbazine)

Completed
Has Results
  • Melanoma
  • Los Angeles, California
  • +18 more
Dec 8, 2020

Plaque Psoriasis Trial in Canada, United States (Roflumilast Cream 0.3%, Roflumilast Cream 0.15%, Vehicle Cream)

Completed
Has Results
  • Plaque Psoriasis
  • Roflumilast Cream 0.3%
  • +2 more
  • Beverly Hills, California
  • +29 more
Aug 31, 2022

SARS-CoV-2 Infection Trial in Silver Spring (25 µg SpFN_1B-06-PL + ALFQ (QS21 Adjuvant), Sodium chloride, USP, for injection

Active, not recruiting
  • SARS-CoV-2 Infection
  • 25 µg SpFN_1B-06-PL + ALFQ (QS21 Adjuvant)
  • +2 more
  • Silver Spring, Maryland
    WRAIR Clinical Trials Center
Sep 13, 2021

Metastatic Breast Cancer Trial in Worldwide (metastatic lesion biopsy)

Suspended
  • Metastatic Breast Cancer
  • metastatic lesion biopsy
  • Brussels, Belgium
  • +59 more
Jan 17, 2023

NSCLC, Urothelial Cancer Trial in Worldwide (Avelumab 800 mg in combination with pemetrexed / carboplatin, Avelumab 800 mg in

Active, not recruiting
Has Results
  • Non-small Cell Lung Cancer
  • Urothelial Cancer
  • Avelumab 800 mg in combination with pemetrexed / carboplatin
  • +3 more
  • Tucson, Arizona
  • +45 more
Oct 13, 2022

Melanoma Trial in Worldwide (Pembrolizumab, Vibostolimab, V937)

Recruiting
  • Melanoma
  • Pembrolizumab
  • +5 more
  • Los Angeles, California
  • +28 more
Jan 25, 2023

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +14 more
  • Biopsy
  • +25 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jul 12, 2022

Acute Myeloid Leukemia Trial in Worldwide (Quizartinib, Intrathecal (IT) triple chemo prophylaxis, Fludarabine)

Recruiting
  • Acute Myeloid Leukemia
  • Loma Linda, California
  • +36 more
Feb 1, 2023

Pertussis Trial in Brisbane (TQL1055, Acellular pertussis vaccine)

Active, not recruiting
  • Pertussis
  • TQL1055
  • Acellular pertussis vaccine
  • Brisbane, Australia
    Q-Pharm
Aug 25, 2021

Hyperlipidemia Trial in Worldwide (Evolocumab, Ezetimibe, Placebo to Evolocumab)

Completed
Has Results
  • Hyperlipidemia
  • Evolocumab
  • +6 more
  • Birmingham, Alabama
  • +243 more
Nov 4, 2022

Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, PD-1 inhibitor, Tenofovir Disoproxil)

Recruiting
  • Hepatitis B, Chronic
  • Vancouver, British Columbia, Canada
  • +31 more
Jan 17, 2023

Refralon®, Concentrate for Solution for Intravenous Injection in

Recruiting
  • Paroxysmal Atrial Fibrillation
  • +2 more
  • Ufa, Bashkortostan Republic, Russian Federation
  • +31 more
Mar 6, 2023

Quaternary Ammonium, Hypersensitivity Trial in Paris (serum punction, skin swab in elbow folds)

Not yet recruiting
  • Quaternary Ammonium
  • Hypersensitivity
  • serum punction
  • skin swab in elbow folds
  • Paris, France
    Bichat Hospital
Jul 28, 2022